Happiest Minds Technologies’ Post

We are thrilled to introduce our startup partners for the SLICE Worldwide 2024! 🎉 These exceptional innovators are bringing groundbreaking solutions to the healthcare industry, and we are honored to have them with us. Sensome, a clinical-stage healthtech start-up, has developed a patented, breakthrough microsensor technology that combines the world's smallest impedance-based sensor with machine-learning algorithms to identify and characterize biological tissues in real-time. Vesalio, is focused on advancing care for patients suffering from vascular occlusion by providing physicians with advanced thrombectomy technology aimed at enhancing clinical outcomes. RapidAI, s the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes. Vena Medical, is providing physicians with the world's smallest camera capable of going inside veins and arteries to help them treat stroke. Spryte Medical, is developing technology to fundamentally transform and improve neurovascular patient care. Still time to register! https://lnkd.in/dq5djbE

What types of cardiac monitoring startups and technologies are investors prioritizing in 2025? This year, we’ve seen a marked increase in funding for startups innovating in voice recognition, non-invasive real-time monitoring, and AI-powered data insights for cardiac care. These emerging technologies are transforming the way heart conditions are diagnosed and managed, offering new levels of accuracy and convenience for both patients and healthcare providers. Swipe to discover 6 innovative startups leading the way in transforming cardiac monitoring! Featured companies: 1. General Prognostics (GPx) 2. Monitra Health 3. Acorai 4. Noah Labs 5. RhythmScience Inc. 6. Kardi Ai #HealthTech #CardiacCare #AI #VoiceRecognition #NonInvasiveMonitoring #TalentStrategy #Innovation ------ We help MedTech innovators build high-performing teams across the US, EMEA and APAC. ✉️ Contact us to learn more: info@plexus-partners.com

𝗠𝗲𝗱𝘁𝗲𝗰𝗵’𝘀 𝗔𝗜 𝗯𝗼𝗼𝘀𝘁 The FDA approved more novel medical technologies than it has in any single year ever before. 👉 Several factors contributed: - approvals of hashtag#AI and hashtag#machinelearning-enabled medtech products reached an all-time high - miniaturization and improved visualization continued to drive approvals in niche segments - digitally enabled categories, such as neuromodulation and robotics, continued to grow steadily Medtech companies adopting generative AI technology are beginning to see productivity benefits and will gain a competitive advantage through early adoption, despite regulatory hurdles and a need for new capabilities and talent. Industry executives expect the pace of innovation to accelerate again this year, which may also bring greater competition. #marketinsights #medtech

𝗠𝗲𝗱𝘁𝗲𝗰𝗵’𝘀 𝗔𝗜 𝗯𝗼𝗼𝘀𝘁 The FDA approved more novel medical technologies than it has in any single year ever before. 👉 Several factors contributed: - approvals of hashtag#AI and hashtag#machinelearning-enabled medtech products reached an all-time high - miniaturization and improved visualization continued to drive approvals in niche segments - digitally enabled categories, such as neuromodulation and robotics, continued to grow steadily Medtech companies adopting generative AI technology are beginning to see productivity benefits and will gain a competitive advantage through early adoption, despite regulatory hurdles and a need for new capabilities and talent. Industry executives expect the pace of innovation to accelerate again this year, which may also bring greater competition. #marketinsights #medtech

Power of AI in Diagnostics: A Game-Changer for Healthcare Startups. The healthcare industry is rapidly evolving and  AI-assisted diagnostics is revolutionising the  way of disease detection, treatment plan and  patient care. This opens up the opportunity for startups in healthcare industry to drive innovation, enhance  operational efficiency and deliver superior patient care. By giving accurate diagnostic solutions, startups can differentiate their offerings and capture market share in the competitive environment. Not just the startups, but the established healthcare  enterprises also can leverage AI-assisted diagnostics to optimise the existing workflow, reduce costs and stay ahead. Key Benefits of AI-Assisted Diagnostics: - Enhanced accuracy. - Streamlined workflows. - Improved clinical decision support. - Scalability and cost-efficiency. AI-assisted diagnostics is a powerful solution to the increasing demand in the healthcare industry. If you are interested in utilising technological  advancements in your organisation- Reach out @ chirag@innovuratech.com #ArtificialIntelligence #Diagnostics #HealthTech

Together with CNA, we look deeper into how startups are using AI, AR and other cutting-edge technologies to pioneer breakthrough innovations that can tackle global challenges. The first instalment of the Deep Tech: Inventing The Future docuseries features Engine Biosciences, backed by ClavystBio, as well as Moon Technologies, showcasing the diverse approaches startups are taking to drive progress and sustain innovation. With ClavystBio’s backing, Engine Biosciences has developed a cutting-edge platform that leverages machine learning and functional genomics to accelerate and increase precision in finding new treatments, particularly for complex diseases like cancer. Identifying promising drug candidates is now faster and at a lower cost than traditional methods, bringing life-changing therapies closer to reality. The support has led to partnerships with top pharmaceutical companies, with promising results in early drug development stages. Moon Technologies, also featured in the episode, is revolutionising emergency medical response with its AR-driven solutions. Their technology provides paramedics with actionable patient insights through a hands-free, eye-tracking heads-up display, enabling faster and more efficient communications. Linked to national electronic health databases, it facilitates real-time telehealth consultations and seamless data transfer to medical facilities, enhancing patient outcomes and streamlining treatment upon arrival. Watch the full episode here: https://lnkd.in/gXrvRNfu #biotech #innovation #venturecapital #startupecosystem

Generative AI is transforming the landscape of HealthTech, pushing boundaries like never before. GlobalLogic's VP of Engineering, Healthcare, and Life Services, Gaurav Gupta, shares how AI solutions drive unprecedented drug discovery, diagnostics, and patient recruitment efficiencies. Learn more about GlobalLogic's cutting-edge Clinical Trials Innovation solution in the full article: https://bit.ly/3zgA9yG #healthcare #pharma #GenAI

👉 𝐐𝐮𝐢𝐜𝐤 𝐁𝐲𝐭𝐞𝐬: Laennec AI Limited, a Cardiff-based MedTech startup, has secured £375K in pre-seed funding to transform smartphones into AI-driven digital stethoscopes. This innovative solution enables users to detect, prevent, and manage asthma exacerbations at home, promoting proactive self-care and reducing emergency hospital visits. The investment, led by SFC Capital and OVC Ventures, with support from the Welsh Government, Innovate UK, and the NIHR (National Institute for Health and Care Research), underscores the growing importance of accessible healthcare technologies. Laennec AI's approach exemplifies the potential of AI in revolutionizing chronic disease management and enhancing patient outcomes. #HealthTech #AI #DigitalHealth #MedTech #Innovation #ChronicDiseaseManagement #AsthmaCare #RemoteMonitoring #SelfCare #HealthcareInnovation | Jase John

Clinical trials can be a financial hurdle for biotech startups. But fear not! LongeVC, have identified innovative ways to cut costs while maintaining research excellence: 𝘈𝘐-𝘱𝘰𝘸𝘦𝘳𝘦𝘥 "𝘱𝘴𝘦𝘶𝘥𝘰 𝘵𝘳𝘪𝘢𝘭𝘴": Simulate real trials using AI to assess drug viability before actual trials, reducing real-world trial costs by using open-source tools like GANerAID. 𝘚𝘺𝘯𝘵𝘩𝘦𝘵𝘪𝘤 𝘥𝘢𝘵𝘢: Leverage anonymized, computer-generated patient data to streamline trials and protect confidentiality, all without compromising results. 𝘋𝘦𝘤𝘦𝘯𝘵𝘳𝘢𝘭𝘪𝘻𝘦𝘥 𝘵𝘳𝘪𝘢𝘭𝘴: Think virtual meetings, mobile blood draws, and mailed samples. Make participation easier for patients, reduce location costs, and boost trial efficiency. These strategies can significantly lower dropout rates and save you money.  #clinicaltrials #biotech #innovation #healthcare